Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?

• Main Authors: Lucia La Sala (Author), Valentina Carlini (Author), Caterina Conte (Author), Maria Belen Macas-Granizo (Author), Elham Afzalpour (Author), Jimmy Martin-Delgado (Author), Marco D'Anzeo (Author), Roberto F.E. Pedretti (Author), Angelo Naselli (Author), Antonio E. Pontiroli (Author), Riccardo Cappato (Author)
• Formato: Livro
• Publicado em: Elsevier, 2024-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Liver and heart disease are major causes of death worldwide. It is known that metabolic alteration causing type 2 diabetes (T2D) and Nonalcoholic fatty liver (NAFLD) coupled with a derangement in lipid homeostasis, may exacerbate hepatic and cardiovascular diseases. Some pharmacological treatments c...